MedTrace Logo

Initial Experience With Spatial Resynchronization Therapy in Patients With Atrial Fibrillation

NCT05461612 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2022-07-18

No results posted yet for this study

Summary

Demonstrate initial safety and performance of Spatial Resynchronization Therapy (SRT) in patients with persistent atrial fibrillation.

Conditions

Interventions

DEVICE

Spatial Resynchronization Therapy delivered by the MAX-SRS, external recording and stimulation device

Delivery of algorithmically defined pacing stimuli over a multitude of electrodes placed on the left atrium.

Sponsors & Collaborators

  • Maxwell Biomedical

    lead INDUSTRY

Principal Investigators

  • George Khabeishvili, MD · Tbilisi Heart and Vascular Clinic

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-23
Primary Completion
2023-06-30
Completion
2023-12-31

Countries

  • Georgia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05461612 on ClinicalTrials.gov